Home・Lista de Ações・Penumbra Inc

Penumbra Inc

Fechado

SetorSaúde

316.87 -0.53

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

316.87

Máximo

317.89

Indicadores-chave
By Trading Economics
Rendimento	2.2M 35M
Vendas	15M 390M
P/E Médio do Setor	78.783 56.432
EPS	0.88
Margem de lucro	8.925
Funcionários	4,700
EBITDA	5.5M 52M

Recomendações
By TipRanks
Recomendações	Neutro
Previsão para 12 meses	+12.85% upside

Dividendos
By Acuity
Próximos Ganhos	4 de nov. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	33M 13B
Abertura anterior	317.4
Fecho anterior	316.87

Sentimento de Notícias

By Acuity

50%

115 / 339 Ranking em Healthcare

Penumbra Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

17 de set. de 2026, 19:46 UTC

Penumbra Inc is trading slightly lower, remaining roughly flat since Wednesday's close and positioned near the lower end of its one-month range.

16 de set. de 2026, 22:06 UTC

Penumbra Inc declined in after-market trading, closing lower than Wednesday's close and remaining below the 20-day moving average amid broader market weakness.

28 de ago. de 2026, 19:36 UTC

Penumbra Inc shares are advancing during Friday's session. The stock's performance aligns with ongoing inflation concerns highlighted by recent Fed comments.

27 de ago. de 2026, 21:01 UTC

Penumbra Inc shares are higher in after-market trading. No specific news was identified to explain this movement, though broader market sentiment remains steady.

26 de ago. de 2026, 20:08 UTC

Penumbra Inc's shares are lower today, impacted by a notable decline in the Health Care Equipment sub-sector. No specific news has been identified.

25 de ago. de 2026, 23:01 UTC

Penumbra Inc shares are higher in after-market trading, recovering from earlier declines amid broader market resilience despite fluctuations linked to falling crude oil prices.

24 de ago. de 2026, 23:11 UTC

Penumbra Inc shares are higher in after-market hours, reflecting notable gains since Monday's close and reaching a session high within its one-month trading range.

22 de ago. de 2026, 00:02 UTC

Penumbra Inc shares are higher in after-market hours, rebounding alongside major stocks and remaining above the 20-day moving average. No specific news was identified.

21 de ago. de 2026, 23:31 UTC

Penumbra Inc's shares are higher in after-market trading, rebounding from an initial decline. The stock is above its 20-day moving average.

17 de ago. de 2026, 19:36 UTC

Correlated Moves

Penumbra Inc. shares are lower today, reflecting broader market declines amid rising bond yields and geopolitical tensions. The stock is near its one-month range high.

10 de ago. de 2026, 19:36 UTC

Correlated Moves

Penumbra Inc shares are higher today, supported by positive trends in the health care equipment sector and the performance of related ETFs.

8 de ago. de 2026, 00:02 UTC

Penumbra Inc shares are trading higher in after-market hours, maintaining strength above the 20-day moving average and near the upper end of their one-month range.

7 de ago. de 2026, 19:56 UTC

Penumbra Inc. shares are lower today, despite earlier gains, amid a broader market influenced by a disappointing jobs report and shifting monetary policy sentiment.

6 de ago. de 2026, 19:36 UTC

Penumbra Inc shares are modestly higher today, maintaining an upward trajectory. No specific company news was identified to explain the price movement.

5 de ago. de 2026, 21:03 UTC

Penumbra Inc shares are higher in after-market hours, though no specific news explains the movement. The stock remains above its 20-day moving average.

4 de ago. de 2026, 19:36 UTC

Penumbra Inc shares are higher today, reflecting a slight gain since Monday. The stock remains above its 20-day moving average amid broader market trends.

3 de ago. de 2026, 21:01 UTC

Penumbra Inc. shares are lower in after-market trading, despite gains in the broader market. The decline began shortly after Monday's close.

24 de jul. de 2026, 16:36 UTC

Correlated Moves

Penumbra Inc's shares are higher today, supported by gains in the medical devices sector and a decline in oil prices easing inflation concerns.

Comparação entre Pares

Variação de preço

Penumbra Inc Previsão

Preço-alvo

By TipRanks

12.85% parte superior

Previsão para 12 meses

Média 358.4 USD 12.85%

Máximo 374 USD

Mínimo 320 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Penumbra Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

6 ratings

Comprar

Manter

Vender

Com base em 6 analistas que deram avaliações de ações para Penumbra Inc - Dist nos últimos 3 meses.

Sentimento

By Acuity

115 / 339 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.